Viral hepatitis A to E in South Mediterranean countries

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 2, Issue 1, 2010, Pages

  Kamal, Sanaa M ^a   Mahmoud, Sara ^a   Hafez, Tamer ^a   EL Fouly , Runia ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALGERIA; DELTA AGENT HEPATITIS; DISEASE ASSOCIATION; EGYPT; ENVIRONMENTAL SANITATION; FOOD CONTAMINATION; GENOTYPE; HEALTH SURVEY; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNIZATION; IMMUNOASSAY; INFECTION CONTROL; INFECTION RISK; LIBYAN ARAB JAMAHIRIYA; MOROCCO; REVIEW; RISK ASSESSMENT; SEROPREVALENCE; STRAIN DIFFERENCE; TUNISIA; URBAN RURAL DIFFERENCE; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

EID: 79952787108     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2010.001     Document Type: Review

References (111)

1. World Health Organization. Hepatitis. Available at: hhttp://www.who.int/topics/hepatitis/en/. Accessed 12/09/2009.
2. Cooke GS, Main J, Thursz MR. Treatment for hepatitis B BMJ. 2010 5;340:b5429
3. Thomas DL, Seeff LB. Natural history of hepatitis C. Clin Liver Dis 2005;9:383-98.
4. World Health Organization. Hepatitis C. Available at: http://www.who.int/water_sanitation_health/diseases/hepatitis/en/index.html Accessed 12/09/2009.
5. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology. 2010;53:15-9.
6. Marano C, Freedman DO. Global health surveillance and travelers' health. Curr Opin Infect Dis. 2009;22:423-9.
7. Couturier E, Roque-Afonso AM, Letort MJ, Dussaix E, Vaillant V, de Valk H. Cluster of cases of hepatitis A with a travel history to Egypt, September-November 2008, France. Euro Surveill. 2009
8. Bernard H, Frank C. Cluster of hepatitis A cases among travellers returning from Egypt, Germany, September through November 2008. Euro Surveill. 2009 22;14.
9. Robesyn E, Micalessi MI, Quoilin S, Naranjo M, Thomas I. Cluster of hepatitis A cases among travellers returning from Egypt, Belgium, September through November 2008. Euro Surveill. 2009 22;14.
10. Salama II, Samy SM, Shaaban FA, Hassanin AI, Abou Ismail LA. Seroprevalence of hepatitis A among children of different socioeconomic status in Cairo. East Mediterr Health J. 2007 Nov-;13:1256-64
11. El-Karaksy H, El-Sayed R, El-Raziky M, El-Koofy N, Mansour S. Cost-effectiveness of prescreening versus empirical vaccination for hepatitis A in Egyptian children with chronic liver disease. East Mediterr Health J. 2008;14:804-9.
12. Omar AA, Hashish MH.. Screening for hepatitis A virus antibodies among a disadvantaged group of preschool children in Alexandria. J Egypt Public Health Assoc. 2000;75:529-39.
13. Meky FA, Stoszek SK, Abdel-Hamid M, Selim S, Abdel-Wahab A, Mikhail N, El-Kafrawy S, El-Daly M, Abdel-Aziz F, Sharaf S, Mohamed MK, Engle RE, Emerson SU, Purcell RH, Fix AD, Strickland GT. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis. 2006;42:628-33.
14. Pintó RM, Alegre D, Domínguez A, El-Senousy WM, Sánchez G, Villena C, Costafreda MI, Aragonès L, Bosch A. Hepatitis A virus in urban sewage from two Mediterranean countries. Epidemiol Infect. 2007;135:270-3.
15. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, Hamid MA, Colombani F, Sultan Y, El-Aidy S, Fontanet A, Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol. 2005;76:520-5
16. Divizia M, Gabrieli R, Stefanoni ML, Renganathan E, El Ghazzawi E, Kader OA, Gamil F, El Sawaf G, El Sherbini E, Saleh E, Degener AM, Noce A, Zaratti L, Modesti A, Panà A. HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol. 1999;15:603-9.
17. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. Am J Trop Med Hyg. 1996;54:554-8.
18. Ward M, Borgen K, Mazick A, Muehlen M. Hepatitis A vaccination policy for travellers to Egypt in eight European countries, 2004. Euro Surveill. 2006;11:37-9.
19. Gebreel AO, Christie AB. Viral hepatitis in children: a study in Libya. Ann Trop Paediatr. 1983;3:9-11.
20. Rezig D, Ouneissa R, Mhiri L, Mejri S, Haddad-Boubaker S, Ben Alaya N, Triki H. Seroprevalences of hepatitis A and E infections in Tunisia Pathol Biol (Paris). 2008;56:148-53.
21. Gharbi-Khelifi H, Sdiri K, Ferre V, Harrath R, Berthome M, Billaudel S, Aouni M. A 1-year study of the epidemiology of hepatitis A virus in Tunisia. Clin Microbiol Infect. 2007
22. Letaief A, Kaabia N, Gaha R, Bousaadia A, Lazrag F, Trabelsi H, Ghannem H, Jemni L. Age-specific seroprevalence of hepatitis a among school children in central Tunisia. Am J Trop Med Hyg. 2005;73:40-3
23. Pröll S, Nothdurft HD. The risk of contracting hepatitis A or hepatitis B run by visitors to the Mediterranean and Eastern Europe MMW Fortschr Med. 2004 13;146:51-4
24. Arya SC, Agarwal N. Hepatitis A and E: Update on prevention and epidemiology. Vaccine. 2009 Dec 29.
25. Fitz Simons D, Hendrickx G, Vorsters A, Van Damme P. A and E: Update on prevention and epidemiology. Vaccine. 2010 8;28:583-8
26. Smahi MC, Rahmoun L, Ghomari SM, Benmansour S, Sendani H, Bendeddouche AS, Gendrel D. Seroprevalence and risk factors of hepatitis A among children in Tlemcen (north-west Algeria. Arch Pediatr. 2009;16:844-6.
27. Hamdi-Cherif M, Touabti A, Belabbes EH. Prevalence of hepatitis virus A in the city of Sétif. Arch Inst Pasteur Alger. 1986;55:285-7.
28. Khalfa S, Ardjoun H. Epidemiology of viral hepatitis in Algeria] Med Trop (Mars). 1984;44:247-52
29. Bouskraoui M, Bourrous M, Amine M. Prevalence of antihepatitis A virus antibodies in chidren in Marrakech. Arch Pediatr. 2009 Oct;16 Suppl 2:S132-6.
30. World Health Organization. Hepatitis. Available at: httphttp://www.who.int/diagnostics_laboratory/evaluations/hepb/en/index.html Accessed: 12/14/2009
31. Margolis HS, Alter MJ, Hadler S. Viral hepatitis. In: Evans AS, Kaslow 1. RA, eds. Viral infections of humans: Epidemiology and control. 4th ed. Springer, 1997:363-418.
32. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000 18;18 Suppl 1:S20-2.
33. Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B. virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 2005;4:13.
34. Sanchez Tapias JM, Costa J, Mas A, et al. Influence of hepatitis B 4. virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 2002;123:1848-56.
35. Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37:S9-S19.
36. Sherif MM, Abou-Aita BA, Abou-Elew MH, el-Kafrawi AO. Hepatitis B virus infection in upper and lower Egypt. J Med Virol. 1985;15:129-35.
37. Ismail AM, Ziada HN, Sheashaa HA, Shehab El-Din AB. Decline of viral hepatitis prevalence among asymptomatic Egyptian blood donors: a glimmer of hope. Eur J Intern Med. 2009;20:490-3
38. El Sherbini A, Mohsen SA, Seleem Z, Ghany AA, Moneib A, Abaza AH. Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: impact of hepatitis B vaccine. Am J Infect Control. 2006;34:600-2.
39. Shaaban FA, Hassanin AI, Samy SM, Salama SI, Said ZN. Longterm immunity to hepatitis B among a sample of fully vaccinated children in Cairo, Egypt. East Mediterr Health J. 2007;13:750-7.
40. Ibrahim S, el-Din S, Bazzal I. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status. J Natl Med Assoc. 2006
41. Zekri AR, Hafez MM, Mohamed NI, Hassan ZK, El-Sayed MH, Khaled MM, Mansour T. Hepatitis B virus (HBV) genotypes in Egyptian pediatric cancer patients with acute and chronic active HBV infection. Virol J. 2007;15;4:74
42. Badr II, Farghaly AG, Koura MR, Mohamed HF, Hassan EM, Kotkat AM. Health status assessment of drug addicts in Alexandria. J Egypt Public Health Assoc. 1998;73:275-96
43. Paez Jimenez A, El-Din NS, El-Hoseiny M, El-Daly M, Abdel-Hamid M, El Aidi S, Sultan Y, El-Sayed N, Mohamed MK, Fontanet A. Community transmission of hepatitis B virus in Egypt: results from a case-control study in Greater Cairo. Int J Epidemiol. 2009;38:757-65.
44. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer. 2009 1;124:690-7.
45. Elzouki A N. Hepatitis B infection in Libya: The magnitude of the problem. The Libyan Journal of Infectious Diseases, 2008, 2: 20-25.
46. Elzouki A, Esmeo M, Samod M, et al. Prevalence of hepatitis B, C and HIV infection in Libya: a population- based nationwide sero- epidemiological study. Liver International 2006; 26: Supp 1, 20
47. Elzouki A, Esmeo M, Samod M, et al. Prevalence of hepatitis B, C and HIV infection in Libya: a population- based nationwide sero- epidemiological study. Liver International 2006; 26: Supp 1, 20
48. Triki H, Said N, Ben Salah A, Arrouji A, Ben Ahmed F, Bouguerra A, Hmida S, Dhahri R, Dellagi K. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg. 1997;91:11-4.
49. Triki H, Ben Slimane S, Ben Mami N, Sakka T, Ben Ammar A, Dellagi K. High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa. Epidemiol Infect. 2000;125:169-74
50. Bahri O, Cheikh I, Hajji N, Djebbi A, Maamouri N, Sadraoui A, Mami NB, Triki H. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol. 2006;78:353-7.
51. Hannachi N, Bahri O, Mhalla S, Marzouk M, Sadraoui A, Belguith A, Triki H, Boukadida J. Hepatitis B virus infection in Tunisian pregnant women: risk factors and viral DNA levels in HBe antigen negative women. Pathol Biol (Paris). 2009;57:e43-7.
52. Langar H, Triki H, Gouider E, Bahri O, Djebbi A, Sadraoui A, Hafsia A, Hafsia R. Blood-transmitted viral infections among haemophiliacs in Tunisia. Transfus Clin Biol. 2005;12:301-5.
53. Meldal BH, Moula NM, Barnes IH, Boukef K, Allain JP. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol. 2009;90:1622-8.
54. Ayed, Z., Houinato, D., Hocine, M., Ranger-Rogez, S., Denis, F. Prevalence of hepatitis B and C among Algerian blood donors and pregnant women. Bulletin de la Société de Pathologie Exotique, 2006. CABI
55. Khelifa F, Thibault V. Characteristics of hepatitis B viral strains in chronic carrier patients from North-East Algeria. Pathol Biol 2009;57:107-13.
56. Sbai A, Bennani A, Benjouad A, Hassar M. HBV genotypes in Morocco J Clin Virol. 2007;38:184-5
57. Ezzikouri S, Chemin I, Chafik A, Wakrim L, Nourlil J, Malki AE, Marchio A, Dejean A, Hassar M, Trepo C, Pineau P, Benjelloun S. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol. 2008;8:306-12
58. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca] Nephrol Ther. 2005;1:274-84
59. World Health Organization. Hepatitis C. Available at: http://www.who.int/vaccineresearch/diseases/viralcancers/en/index2.html. Accessed 11/29/2009.
60. The Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004;44:20-9.
61. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67
62. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology. 2006;43:915-22
63. Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, et al. Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 2000;20:281-289.
64. Simmonds P, Holmes EC, Cha T-A, Chan SW, McOmish F, Irvine B, et al. Classification of hepatitis C virus into six major genotypes and a seriesof subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993;74:2391-2399.
65. Bhattacherjee V, Prescott LE, Pike I, Rodgers B, Bell H, El-Zayadi AR, et al. Use of NS-4 peptides to identify type specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol 1995;76:1737-1748.
66. Chamberlain R, Adams N, Saeed AA, Simmonds P, Elliott RM. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant in the Middle East. J Gen Virol 1997;78:1341-1347.
67. Zakaria S, Fouad R, Shaker O, Zaki S, Hashem A, El-Kamary SS, Esmat G, Zakaria S. Changing patterns of acute viral hepatitis at a major urban referral center in Egypt. Clin Infect Dis. 2007 15;44:e30-6.
68. Meky FA, Stoszek SK, Abdel-Hamid M, et al. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta. Clin Infect Dis 2006;42:628-33.
69. Bakr I, Rekacewicz C, El Hosseiny M, et al. Higher clearance of hepatitis C virus infection in females compared with males. Gut 2006;55:1183-7.
70. Magder LS, Fix AD, Mikhail NN, et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol 2005;34:160-5
71. Kamal SM, Amin A, Madwar M, et al. Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004;78:12252-8.
72. Kamal SM, Nasser I. Hepatitis C genotype 4: What we now and what we do not yet know.. Hepatology. 2008;47:1371-83.
73. El Katsha S, Labeeb S, Watts S, et al. Informal health providers and the transmission of hepatitis C virus: Pilot study in two Egyptian villages. East Mediterr Health J 2006;12:758-67
74. Stoszek SK, Abdel-Hamid M, Narooz S, et al. Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women. Trans R Soc Trop Med Hyg 2006;100:102-7.
75. Talaat M, Kandeel A, El-Shoubary W, et al. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control 2003;31:469-74
76. Mohamed MK, Abdel-Hamid M, Mikhail NN, et al. Intrafamilial transmission of hepatitis C in Egypt. Hepatology 2005;42:683-7.
77. Kamal SM, Ismail A, Graham CS, et al. Pegylated interferon a therapy in acute hepatitis C: Relation to hepatitis C virusspecific T cell response kinetics. Hepatology 2004;39:1721-31
78. Kamal SM, Moustafa KN, Chen J, et al. Duration of peginterferon therapy in acute hepatitis C: A randomized trial. Hepatology 2006;43:923-31.
79. Saleh, M. G., Pereira, L. M. M. B., Tibbs, C. J., Ziu, M et al. High prevalence of hepatitis C virus in the normal Libyan population. Tropical Medicine and Hygiene, 1994; 88: 292-294.
80. Elzouki A, Esmeo M, Samod M, et al. Prevalence of hepatitis B, C and HIV infection in Libya: a population- based nationwide sero- epidemiological study. Liver International 2006; 26: Supp 1, 20.
81. Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Med J. 2002;23:1356-60.
82. Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya. J Hosp Infect. 2009;72:258-61
83. Yerly S, Quadri R, Negro F, Barbe KP, Cheseaux JJ, Burgisser P, Siegrist CA, Perrin L. Nosocomial outbreak of multiple bloodborne viral infections. J Infect Dis. 2001 1;184:369-72
84. Sassi F, Gorgi Y, Ayed K, Abdallah TB, Lamouchi A, Maiz HB. Hepatitis C virus antibodies in dialysis patients in Tunisia: a single center study. Saudi J Kidney Dis Transpl. 2000;11:218-22.
85. Djebbi, A, Triki, H, Bahri, O. et al.: Genotypes of hepatitis C virus circulating in Tunisia. Epidemiol. Infect. 2003, 130: 501-505.
86. National Travel Health Network and Centre (NaTHNaC): Country Information, Algeria, Tunisia and Morocco, 2009
87. Beghdadli B, Ghomari O, Taleb M, Belhaj Z, Belabed A, Kandouci del AK, Fanello S. Personnel at risk for occupational blood exposure in a university hospital in West Algeria Sante Publique. 2009;21:253-6
88. Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M. Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction. Pathol Biol 2009, 57:368-72.
89. Sekkat S, Kamal N, Benali B, Fellah H, Amazian K, Bourquia A, El Kholti A, Benslimane A. Prevalence of anti-HCV antibodies and seroconversion incidence in five haemodialysis units in Morocco. Nephrol Ther. 2008;4:105-10
90. Boulaajaj K, Elomari Y, Elmaliki B, Madkouri B, Zaid D, Benchemsi N. Prevalence of hepatitis C, hepatitis B and HIV infection among haemodialysis patients in Ibn-Rochd university hospital, Casablanca. Nephrol Ther. 2005;1:274-84
91. Zahraoui-Mehadji M, Baakrim MZ, Laraqui S, Laraqui O, El Kabouss Y, Verger C, Caubet A, Laraqui CH. Infectious risks associated with blood exposure for traditional barbers and their customers in Morocco. Sante. 2004;14:211-6.
92. Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010;7:31-40.
93. Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009;50:1043-50.
94. Darwish MA, Shaker M, Raslan OS, Abdel-Raouf T. Delta virus infection in Egypt. J Egypt Public Health Assoc. 1992
95. el-Zimaity DM, Hyams KC, Imam IZ, Watts DM, Bassily S, Naffea EK, Sultan Y, Emara K, Burans J, Purdy MA, et al. Acute sporadic hepatitis E in an Egyptian pediatric population. Am J Trop Med Hyg. 1993;48:372-6.
96. Saudy N, Sugauchi F, Tanaka Y, Suzuki S, Aal AA, Zaid MA, Agha S, Mizokami M. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt. J Med Virol. 2003;70:529-36
97. Morcos MM, Mikhail TH, Hanna WM, Abdel-Fattah S, el-Rasad MM, Wassef EL. The prevalence of delta virus infection in chronic liver disease in Egyptian children in comparison with some other countries. Panminerva Med. 2000;42:97-100.
98. Rioche M, Himmich H, Hansson BG, Nordenfelt E. Low occurrence of delta agent infections in Morocco. Bull Soc Pathol Exot Filiales. 1987;80:741-4.
99. Meng XJ. Recent advances in Hepatitis E Virus. J Viral Hepat. 2009;21.
100. FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine. 2010 8;28:583-8.
101. Blackard JT, Rouster SD, Nady S, Galal G, Marzuuk N, Rafaat MM, Daef E, El Din SS, Purcell RH, Emerson SU, Sherman KE, Shata MT. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. J Clin Virol. 2009;46:140-4.
102. Stoszek SK, Engle RE, Abdel-Hamid M, Mikhail N, Abdel-Aziz F, Medhat A, Fix AD, Emerson SU, Purcell RH, Strickland GT. Hepatitis E antibody seroconversion without disease in highly endemic rural Egyptian communities. Trans R Soc Trop Med Hyg. 2006;100:89-94.
103. Darwish MA, Faris R, Darwish N, Shouman A, Gadallah M, El-Sharkawy MS, Edelman R, Grumbach K, Rao MR, Clemens JD. Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. Am J Trop Med Hyg. 2001;64:147-53.
104. Fix AD, Abdel-Hamid M, Purcell RH, Shehata MH, Abdel-Aziz F, Mikhail N, el Sebai H, Nafeh M, Habib M, Arthur RR, Emerson SU, Strickland GT. Prevalence of antibodies to hepatitis E in two rural Egyptian communities. Am J Trop Med Hyg. 2000;62:519-23
105. Stoszek SK, Abdel-Hamid M, Saleh DA, El Kafrawy S, Narooz S, Hawash Y, Shebl FM, El Daly M, Said A, Kassem E, Mikhail N, Engle RE, Sayed M, Sharaf S, Fix AD, Emerson SU, Purcell RH, Strickland GT. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg. 2006;100:95-101.
106. Ghannoum MA, Moore KE, Al-Dulaimi M, Nasr M. The incidence of water-related diseases in the Brak area, Libya from 1977 to 1979, before and after the installation of water treatment plants. Zentralbl Bakteriol Mikrobiol Hyg B. 1981;173:501-8.
107. Hannachi N, Hidar S, Harrabi I, Mhalla S, Marzouk M, Ghzel H, Ghannem H, Khairi H, Boukadida J. Seroprevalence and risk factors of hepatitis E among pregnant women in central Tunisia.] Biol (Paris). 2009 Nov 4.
108. van Cuyck-Gandré H, Zhang HY, Tsarev SA, Clements NJ, Cohen SJ, Caudill JD, Buisson Y, Coursaget P, Warren RL, Longer CF. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence. J Med Virol. 1997;53:340-7.
109. Grandadam M, Tebbal S, Caron M, Siriwardana M, Larouze B, Koeck JL, Buisson Y, Enouf V, Nicand E. Evidence for hepatitis E virus quasispecies. J Gen Virol. 2004;85:3189-94.
110. Bernal MC, Leyva A, Garcia F, Galan I, Piedrola G, Heyermann H, Maroto MC. Seroepidemiological study of hepatitis E virus in different population groups. Eur J Clin Microbiol Infect Dis. 1995;14:954-8.
111. Benjelloun S, Bahbouhi B, Bouchrit N, Cherkaoui L, Hda N, Mahjour J, Benslimane A. Seroepidemiological study of an acute hepatitis E outbreak in Morocco. Res Virol. 1997;148:279-87.